Brief: Aker Biomarine Q1 Adjusted EBITDA $12.5 Mln
30/04/2026 06:11
April 30 (Reuters) - Aker Biomarine ASA AKBM.OL: AKER BIOMARINE Q1 ADJUSTED EBITDA USD 12.5 MILLION AKER BIOMARINE Q1 REVENUE USD 57.3 MILLION FOLLOWING RECENT INTEREST IN HUMAN HEALTH INGREDIENT BUSINESS UNIT, CO IS EXPLORING ALTERNATIVES, WORKING TOWARDS TRANSACTION IN 2026 Source text: ID:nObi1byVka Further company coverage: AKBM.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Aker Biomarine ASA
See all newsBrief: Aker ASA: Conditions For Completion Of Merger With Aker Biomarine Satisfied
Brief: Aker Capital Buys 933,110 Aker BioMarine Shares
Brief: Aker Biomarine To Hold EGM On August 17
Brief: Aker Biomarine: Optional Cash Offer To Shareholders
Brief: Aker Biomarine: Proposed Merger And Optional Cash Offer